Back to search results

Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin

Abroad (travel likely)Recruiting

Conditions

Crohn Disease (CD) · Ileocolic Resection · Post-endoscopic Operative Reccurence

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHU d'Amiens, Amiens, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Mathurin FUMERY)

  • CHU de Clermont-Ferrand, Clermont-Ferrand, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Anthony Buisson)

  • CHU de Lille, Lille, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Maria NACHURY)

  • HCL, Lyon, France

    Contact: Study coordinator (Lise Laclautre) · promo_interne_drci@chu-clermontferrand.fr
    Contact: Principal Investigator (Stéphane NANCEY)

  • AP-HM, Marseille, France

    Contact: Study coordinator (Lise Laclautre) · promo_interne_drci@chu-clermontferrrand.fr
    Contact: Principal Investigator (Lucas Guillo)

  • CHU de Montpellier, Montpellier, France

    Contact: Study coordinator (Lise Laclautre)
    Contact: Principal Investigator (Romain ALTWEGG)

  • Chu de Nice, Nice, France

    Contact: Study coordinator (Lise Laclautre) · promo_interne_drci@hu-clermontferrand.fr
    Contact: Principal Investigator (Adrien Nicolau)

  • CHU de Toulouse, Toulouse, France

    Contact: Study coordinator (Lise LACLAUTRE) · promo_interne_drci@chu-clermontferrand.fr
    Contact: Principal Investigator (Cyrielle GILLETTA DE SAINT-JOSEPH)
Study leads

  • Anthony Buisson

    Principal Investigator

    University Hospital, Clermont-Ferrand

View source on ClinicalTrials.gov(opens in a new tab)